Defective Drug and Medical Device Cases Against Pharmaceuticals

Vyotorin

Vytorin is a combination drug made up of the compounds simvastatin and ezetimibe that's designed to reduce levels of LDL (bad) cholesterol and cut the risk of cardiovascular problems. It works by decreasing the production of cholesterol by the liver and inhibiting the absorption of cholesterol in the intestine ... read more.

Nephrogenic Systemic Fibrosis (NSF) and Gadolinium

The Food and Drug Administration (FDA) has asked the manufacturers of gadolinium-based contrast agents to include a new boxed warning that alerts consumers of the potential development of NFS / NFD (Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy)... read more.

Zicam

ZICAM, manufactured by Matrixx Initiatives, Inc., and Cold-Eeze, manufactured by the Quigley Corporation, are homeopathic nasal medications that are claimed to shorten the duration and minimize the symptoms associated with the common cold ... read more.

Vioxx

Vioxx is an arthritis drug manufactured by Merck. The drug was pulled from the market September 29, 2004 after a clinical trial confirmed long-standing concerns that the drug raises the risk of heart attack and stroke for people who use the drug more than 18 months ... read more.

Prempro

Prempro is a hormone replacement treatment marketed by the Wyeth pharmaceutical company. The drug was designed to treat menopausal symptoms including hot flashes, night sweats and vaginal dryness. There was an initial belief that Hormone Replacement Therapy could also reduce a woman’s risk of osteoporosis and heart complications ... read more.

Rezulin

Rezulin was a drug for thetreatment of Type II Diabetes.Also known as Troglitazone, Rezulin was designed to treat Type II Diabetes at a cellular level. It was put on the market by Parke Davis (a division of Warner Lambert) and marketed by the company as having side effects comparable to placebo. The drug was shown to cause severe liver toxicity and removed from the market in March of 2000 ... read more.

Baycol

Baycol is one of an extraordinarily popular family of cholesterol-lowering drugs called "statins.". It was brought to the market in 1997 by the German drug manufacturer Bayer AG. In August of 2001 it was pulled from the market due to 31 US deaths involving the drug ... read more.

Zithromax (Z-Pack)

Zithromax® (Azithromycin) is a highly popular but very potent antibiotic sold by Pfizer. It is commonly know as the Z-pack. It is prescribed for treatment of mild to moderate infections and is taken as one pill per day for five days. Zithromax has been reported to cause liver damage including elevated liver enzymes, jaundice, liver failure leading to transplantation and even death ... read more.

Zyprexa

Zyprexa is a psychotropic agent. It is the most frequently prescribed drugs for schizophrenia. Zyprexa has recently been linked with diabetes. The FDA is now requiring a warning on Zyprexa saying that is linked with diabetes, hyperglycemia and other blood sugar disorders ... read more.

Celebrex

Celebrex is an arthritis/painkiller drug manufactured by Pfizer. Recent studies linked Celebrex to an increased risk of serious cardiovascular events, including heart attacks and strokes ... read more.

Bextra

Recent studies show that patients who take Bextra have an increased risk of heart attacks, strokes and blood clots. Bextra is the a drug in the same chemical class as Vioxx and may cause the same type of adverse events. Bextra has also been linked to a very rare but dangerour condition called Stevens Johnson Syndrome. This is an extreme allergic reaction to chemicals ... read more.

Ortho Evra

The Food and Drug Administration recently approved a new warning label for Ortho Evra, stating in bold letters that the patch exposes women to about 60% more estrogen than the birth control pill. The makers of Ortho Evra previously failed to warn users of the higher estrogen levels, which may increase the risk of heart attack, stroke and death ... read more.

ReNu with Moisture Loc Contact Lens Solution

On April 10, 2006, Bausch & Lomb announced suspension of shipments of its contact solution ReNu with MoistureLoc. Reports of fungal keratitis infections in users of the solution are surfacing in contact lens wearers who use ReNu with MoistureLoc ... read more.

PPA

The drug phenylpropanolamine (PPA) is used as an ingredient in many common over-the-counter and prescription cough and cold medicines (such as Robitussin and Alka-Seltzer). Recent studies have shown that taking PPA can increase the risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain). The FDA is currently taking steps to remove all products containing this drug from the market ... read more.

Serzone

Serzone is an oral antidepressant marketed by Bristol Myers Squibb Pharmaceutical Company. The drug is indicated to treat moderate to severe symptoms of depression. In December of 2001, the FDA notified Bristol Myers that it must include a black box warning on the label of Serzone to inform patients and doctors that it may cause life threatening liver damage in some patients. The warning estimates that Serzone increases your chance of liver failure by three to four times ... read more.

Fen-Phen

The popular diet drug combination, Fen - Phen, involved the combination use of Fenfluramine (known as Pondimin) and Phentermine (Fastin, Adipex, Zantryl etc.) or Dexfenfluramine (Redux). The drug manufacturer, American Home Products, removed both Pondimin and Redux from the market in September of 1997. These drugs cause two different health problems ... read more.

Sulzer Hip Implants

On December 8, 2000, Sulzer Orthopedics, Inc. announced the recall of its Inter-Op acetabular shell for hip implants which has affected over 17,000 patients to date. Due to a manufacturing problem, some products were left with machine oil on hip joint replacements ... read more.

Stryker Pain Pump

A recently published study has shown that the use of intra-articular pain pump catheters following shoulder surgery may cause permanent cartilage damage.... read more.